Vor Bio to Participate in Upcoming Investor Conferences
Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company focused on autoimmune disease treatments, has announced its participation in two upcoming investor conferences. The company will participate in a fireside chat at Citi's 2025 Biopharma Back to School Conference on September 2nd, 2025, at 11:15am ET in Boston. Additionally, Vor Bio will hold one-on-one investor meetings at the Baird 2025 Global Healthcare Conference on September 9th, 2025, in New York.
A live webcast of the Citi conference fireside chat will be accessible through the company's investor relations website at www.vorbio.com, where an archived replay will also be available.
Vor Bio (Nasdaq: VOR), società biotecnologica in fase clinica che sviluppa terapie per le malattie autoimmuni, ha comunicato la sua partecipazione a due prossimi incontri con investitori. Il 2 settembre 2025 alle 11:15 ET a Boston, la società sarà protagonista di una fireside chat al Citi's 2025 Biopharma Back to School Conference. Inoltre, il 9 settembre 2025 a New York Vor Bio terrà incontri individuali con investitori al Baird 2025 Global Healthcare Conference.
La fireside chat al Citi sarà trasmessa in diretta via webcast sul sito investor relations della società all'indirizzo www.vorbio.com, dove sarà disponibile anche la registrazione on demand.
Vor Bio (Nasdaq: VOR), compañía biotecnológica en fase clínica centrada en tratamientos para enfermedades autoinmunes, ha anunciado su participación en dos próximos eventos para inversores. El 2 de septiembre de 2025 a las 11:15 ET en Boston, la empresa participará en una charla frente a una chimenea en el Citi's 2025 Biopharma Back to School Conference. Además, el 9 de septiembre de 2025 en Nueva York, Vor Bio celebrará reuniones individuales con inversores en el Baird 2025 Global Healthcare Conference.
La charla del Citi se transmitirá en directo por webcast a través del sitio de relaciones con inversores de la compañía en www.vorbio.com, donde también estará disponible la grabación archivada.
Vor Bio (나스닥: VOR)는 자가면역 질환 치료제 개발에 집중하는 임상 단계의 바이오테크 기업으로, 다가오는 두 건의 투자자 행사에 참여할 예정이라고 발표했습니다. 2025년 9월 2일 오전 11시 15분(동부표준시) 보스턴에서 열리는 Citi's 2025 Biopharma Back to School Conference에서 파이어사이드 채트에 참여합니다. 또한 2025년 9월 9일 뉴욕에서 열리는 Baird 2025 Global Healthcare Conference에서 일대일 투자자 미팅을 진행할 예정입니다.
Citi 행사 파이어사이드 채트는 회사 투자자 관계 웹사이트 www.vorbio.com을 통해 생중계되며, 이후 아카이브 재생도 제공됩니다.
Vor Bio (Nasdaq: VOR), société biotechnologique en phase clinique axée sur les traitements des maladies auto-immunes, a annoncé sa participation à deux prochains événements investisseurs. Le 2 septembre 2025 à 11h15 ET à Boston, la société participera à une discussion informelle lors du Citi's 2025 Biopharma Back to School Conference. Par ailleurs, le 9 septembre 2025 à New York, Vor Bio tiendra des réunions individuelles avec des investisseurs lors du Baird 2025 Global Healthcare Conference.
La discussion lors de la conférence Citi sera diffusée en direct par webcast sur le site relations investisseurs de la société, www.vorbio.com, où un enregistrement sera également consultable en archive.
Vor Bio (Nasdaq: VOR), ein biotechnologisches Unternehmen in der klinischen Phase mit Schwerpunkt auf Therapien für Autoimmunerkrankungen, hat seine Teilnahme an zwei bevorstehenden Investorenveranstaltungen angekündigt. Am 2. September 2025 um 11:15 Uhr ET in Boston wird das Unternehmen an einem Fireside-Chat auf der Citi's 2025 Biopharma Back to School Conference teilnehmen. Außerdem führt Vor Bio am 9. September 2025 in New York Einzelgespräche mit Investoren auf der Baird 2025 Global Healthcare Conference.
Der Fireside-Chat auf der Citi-Konferenz wird live per Webcast über die Investor-Relations-Website des Unternehmens unter www.vorbio.com übertragen; eine Archivaufzeichnung wird ebenfalls verfügbar sein.
- None.
- None.
CAMBRIDGE, Mass., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that it will participate in the following upcoming investor conferences:
Citi's 2025 Biopharma Back to School Conference
Fireside Chat: Tuesday, September 2nd, 2025, at 11:15am ET
Location: Boston, MA
A live webcast and archived replay of the fireside chat will be available on the investors section of www.vorbio.com.
Baird 2025 Global Healthcare Conference
1x1 Investor Meetings: Tuesday, September 9th, 2025
Location: New York, NY
About Vor Bio
Vor Bio is a clinical-stage biotechnology company transforming the treatment of autoimmune diseases. The Company is focused on rapidly advancing telitacicept, a novel dual-target fusion protein, through Phase 3 clinical development and commercialization to address serious autoantibody-driven conditions worldwide. For more information visit www.vorbio.com.
Media & Investor Contacts:
Carl Mauch
cmauch@vorbio.com
Sarah Spencer
investors@vorbio.com
FAQ
When is Vor Bio's fireside chat at Citi's 2025 Biopharma Conference?
Where can investors watch Vor Bio's Citi conference presentation?
What conferences will Vor Bio (VOR) attend in September 2025?
What type of meetings will Vor Bio hold at the Baird 2025 Global Healthcare Conference?
